(Q37800096)

23 August 2017

title

Imaging dopamine transporters in Parkinson's disease (English)

1 reference

23 August 2017

0 references

1 reference

David J Brooks

1

1 reference

23 August 2017

publication date

1 October 2010

1 reference

23 August 2017

published in

Biomarkers in Medicine

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

651-660

1 reference

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

23 August 2017

cites work

1 reference

Executive and mnemonic functions in early Huntington's disease

21 January 2018

1 reference

Dopamine transporter: Basic aspects and neuroimaging

21 January 2018

1 reference

Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs

21 January 2018

1 reference

Technology insight: imaging neurodegeneration in Parkinson's disease.

21 January 2018

1 reference

Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease

21 January 2018

1 reference

[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

21 January 2018

1 reference

Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters

21 January 2018

1 reference

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

21 January 2018

1 reference

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

21 January 2018

1 reference

Role of DAT-SPECT in the diagnostic work up of parkinsonism

21 January 2018

1 reference

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis

21 January 2018

1 reference

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.

21 January 2018

1 reference

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes

21 January 2018

1 reference

Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study

21 January 2018

1 reference

Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA.

21 January 2018

1 reference

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study

21 January 2018

1 reference

Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

21 January 2018

1 reference

Levodopa and the progression of Parkinson's disease

21 January 2018

1 reference

Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.

21 January 2018

1 reference

Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs).

21 January 2018

1 reference

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

21 January 2018

1 reference

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

21 January 2018

1 reference

[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease

21 January 2018

1 reference

[123I]FP-CIT SPET imaging in drug-induced Parkinsonism.

21 January 2018

1 reference

Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism.

21 January 2018

1 reference

Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.

21 January 2018

1 reference

Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review

21 January 2018

1 reference

The role of radiotracer imaging in Parkinson disease

21 January 2018

1 reference

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

Slowing Parkinson's disease progression: recent dopamine agonist trials

21 January 2018

1 reference

PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation

21 January 2018

1 reference

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

21 January 2018

1 reference

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

21 January 2018

1 reference

Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs).

21 January 2018

1 reference

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.

21 January 2018

1 reference

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

21 January 2018

1 reference

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

PET demonstrates reduced dopamine transporter expression in PD with dyskinesias

21 January 2018

1 reference

Levodopa-induced dyskinesias in Parkinson disease are independent of the extent of striatal dopaminergic denervation: a pharmacological and SPECT study.

21 January 2018

1 reference

Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease

21 January 2018

1 reference

Higher dopamine transporter density in Parkinson's disease patients with depression

21 January 2018

1 reference

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

21 January 2018

1 reference

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies.

21 January 2018

1 reference

Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

21 January 2018

1 reference

Differential distribution of striatal [123I]beta-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography.

21 January 2018

1 reference

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients

21 January 2018

1 reference

[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain.

21 January 2018

1 reference

Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration

21 January 2018

1 reference

PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/BMM.10.86

1 reference

23 August 2017

1 reference